

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.98297993 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.98297993 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.65192125 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.22810663 |
| 5 | detection of other organism (GO:0098543) | 4.52049173 |
| 6 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.40627677 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.39877428 |
| 8 | negative regulation of cell killing (GO:0031342) | 4.39877428 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 4.38997508 |
| 10 | leukocyte aggregation (GO:0070486) | 4.34151864 |
| 11 | detection of bacterium (GO:0016045) | 4.33932785 |
| 12 | positive thymic T cell selection (GO:0045059) | 4.30826628 |
| 13 | negative thymic T cell selection (GO:0045060) | 4.24151863 |
| 14 | negative T cell selection (GO:0043383) | 4.23978099 |
| 15 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.23076386 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.17607192 |
| 17 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.10246391 |
| 18 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.93293135 |
| 19 | negative regulation of T cell mediated immunity (GO:0002710) | 3.93182928 |
| 20 | response to peptidoglycan (GO:0032494) | 3.91752774 |
| 21 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.88115508 |
| 22 | detection of external biotic stimulus (GO:0098581) | 3.84538660 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 3.84054411 |
| 24 | thymic T cell selection (GO:0045061) | 3.80680445 |
| 25 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.74951720 |
| 26 | detection of molecule of bacterial origin (GO:0032490) | 3.68396938 |
| 27 | T cell migration (GO:0072678) | 3.53043217 |
| 28 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.52634287 |
| 29 | response to host immune response (GO:0052572) | 3.52634287 |
| 30 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.49294208 |
| 31 | microglial cell activation (GO:0001774) | 3.46770316 |
| 32 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.45233047 |
| 33 | myeloid cell activation involved in immune response (GO:0002275) | 3.45166217 |
| 34 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.42054422 |
| 35 | detection of biotic stimulus (GO:0009595) | 3.34902457 |
| 36 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.34222376 |
| 37 | T cell selection (GO:0045058) | 3.33944807 |
| 38 | positive T cell selection (GO:0043368) | 3.32492102 |
| 39 | positive regulation of lamellipodium assembly (GO:0010592) | 3.31518705 |
| 40 | response to host (GO:0075136) | 3.30097821 |
| 41 | response to host defenses (GO:0052200) | 3.30097821 |
| 42 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.30097821 |
| 43 | regulation of regulatory T cell differentiation (GO:0045589) | 3.29641959 |
| 44 | response to interleukin-15 (GO:0070672) | 3.29408848 |
| 45 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.28967965 |
| 46 | regulation of B cell differentiation (GO:0045577) | 3.27425410 |
| 47 | immunoglobulin mediated immune response (GO:0016064) | 3.27376054 |
| 48 | hepatocyte apoptotic process (GO:0097284) | 3.27096822 |
| 49 | leukocyte cell-cell adhesion (GO:0007159) | 3.23927850 |
| 50 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.23569651 |
| 51 | B cell receptor signaling pathway (GO:0050853) | 3.22820257 |
| 52 | regulation of mast cell degranulation (GO:0043304) | 3.17939520 |
| 53 | macrophage activation (GO:0042116) | 3.17845997 |
| 54 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.16857606 |
| 55 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.16518502 |
| 56 | cellular extravasation (GO:0045123) | 3.14633366 |
| 57 | interferon-gamma production (GO:0032609) | 3.14412666 |
| 58 | neutrophil mediated immunity (GO:0002446) | 3.13140338 |
| 59 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.10962926 |
| 60 | endothelial tube morphogenesis (GO:0061154) | 3.09271028 |
| 61 | morphogenesis of an endothelium (GO:0003159) | 3.09271028 |
| 62 | positive regulation of mast cell activation (GO:0033005) | 3.08330588 |
| 63 | leukocyte degranulation (GO:0043299) | 3.07746119 |
| 64 | regulation of T cell tolerance induction (GO:0002664) | 3.07423295 |
| 65 | tolerance induction (GO:0002507) | 3.07304726 |
| 66 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.05030993 |
| 67 | NIK/NF-kappaB signaling (GO:0038061) | 3.03292082 |
| 68 | defense response to protozoan (GO:0042832) | 3.02684644 |
| 69 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.02442317 |
| 70 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.02442317 |
| 71 | dendritic cell chemotaxis (GO:0002407) | 3.01451188 |
| 72 | germinal center formation (GO:0002467) | 3.01363893 |
| 73 | neutrophil activation involved in immune response (GO:0002283) | 3.01138331 |
| 74 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.00646944 |
| 75 | T cell costimulation (GO:0031295) | 2.99822281 |
| 76 | dendritic cell migration (GO:0036336) | 2.98974011 |
| 77 | positive regulation of B cell differentiation (GO:0045579) | 2.96383502 |
| 78 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.95824931 |
| 79 | actin nucleation (GO:0045010) | 2.94476236 |
| 80 | lymphocyte costimulation (GO:0031294) | 2.93767061 |
| 81 | positive regulation of granulocyte differentiation (GO:0030854) | 2.92047993 |
| 82 | positive regulation of lamellipodium organization (GO:1902745) | 2.91354000 |
| 83 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.90215388 |
| 84 | negative regulation of innate immune response (GO:0045824) | 2.89852403 |
| 85 | interferon-gamma secretion (GO:0072643) | 2.89727504 |
| 86 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.89480038 |
| 87 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.89331851 |
| 88 | regulation of mast cell activation (GO:0033003) | 2.89136020 |
| 89 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.86823521 |
| 90 | cellular response to interleukin-15 (GO:0071350) | 2.85987095 |
| 91 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.83982871 |
| 92 | cellular response to zinc ion (GO:0071294) | 2.83199581 |
| 93 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.79775940 |
| 94 | B cell mediated immunity (GO:0019724) | 2.78684916 |
| 95 | T cell receptor signaling pathway (GO:0050852) | 2.78403906 |
| 96 | natural killer cell differentiation (GO:0001779) | 2.77934372 |
| 97 | response to type I interferon (GO:0034340) | 2.77812105 |
| 98 | negative regulation of phagocytosis (GO:0050765) | 2.77003540 |
| 99 | regulation of response to interferon-gamma (GO:0060330) | 2.76585674 |
| 100 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.75663182 |
| 101 | neutrophil activation (GO:0042119) | 2.74819412 |
| 102 | barbed-end actin filament capping (GO:0051016) | 2.74333628 |
| 103 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.74058722 |
| 104 | type I interferon signaling pathway (GO:0060337) | 2.73227277 |
| 105 | cellular response to type I interferon (GO:0071357) | 2.73227277 |
| 106 | positive regulation of tolerance induction (GO:0002645) | 2.72317190 |
| 107 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.71998747 |
| 108 | positive regulation of isotype switching (GO:0045830) | 2.71500768 |
| 109 | sequestering of actin monomers (GO:0042989) | 2.71497234 |
| 110 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.68102507 |
| 111 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.67849081 |
| 112 | establishment of endothelial barrier (GO:0061028) | 2.65595031 |
| 113 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.64840425 |
| 114 | response to muramyl dipeptide (GO:0032495) | 2.63703890 |
| 115 | positive regulation by symbiont of host defense response (GO:0052509) | 2.63202563 |
| 116 | modulation by symbiont of host defense response (GO:0052031) | 2.63202563 |
| 117 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.63202563 |
| 118 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.63202563 |
| 119 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.63202563 |
| 120 | modulation by symbiont of host immune response (GO:0052553) | 2.63202563 |
| 121 | negative regulation of interleukin-12 production (GO:0032695) | 2.61324264 |
| 122 | regulation of tolerance induction (GO:0002643) | 2.58574721 |
| 123 | granulocyte activation (GO:0036230) | 2.54320197 |
| 124 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.53885502 |
| 125 | myeloid dendritic cell activation (GO:0001773) | 2.53789973 |
| 126 | positive regulation of antigen processing and presentation (GO:0002579) | 2.53115385 |
| 127 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.52906787 |
| 128 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.52906787 |
| 129 | viral transcription (GO:0019083) | 2.51868411 |
| 130 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.51579233 |
| 131 | angiogenesis involved in wound healing (GO:0060055) | 2.51008656 |
| 132 | response to laminar fluid shear stress (GO:0034616) | 2.49383212 |
| 133 | activated T cell proliferation (GO:0050798) | 2.48783080 |
| 134 | natural killer cell activation (GO:0030101) | 2.47752219 |
| 135 | respiratory burst (GO:0045730) | 2.47249650 |
| 136 | pinocytosis (GO:0006907) | 2.46927535 |
| 137 | heterotypic cell-cell adhesion (GO:0034113) | 2.46044526 |
| 138 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.45633193 |
| 139 | ribosomal small subunit assembly (GO:0000028) | 2.44895894 |
| 140 | mast cell activation (GO:0045576) | 2.44882599 |
| 141 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.44855141 |
| 142 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.43929908 |
| 143 | myeloid dendritic cell differentiation (GO:0043011) | 2.43768436 |
| 144 | T cell proliferation (GO:0042098) | 2.42674197 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.88154471 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.49997210 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.43101281 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.40153458 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.20390253 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.96213843 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.94208831 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.84628366 |
| 9 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.77222531 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.70667808 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.56187032 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.50365781 |
| 13 | * MAF_26560356_Chip-Seq_TH1_Human | 2.48283936 |
| 14 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.43974284 |
| 15 | * MYB_26560356_Chip-Seq_TH2_Human | 2.34260580 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.33409531 |
| 17 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23657021 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.19353872 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.18325185 |
| 20 | UTX_26944678_Chip-Seq_JUKART_Human | 2.17550973 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.17500684 |
| 22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.16907367 |
| 23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.10677651 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.03995059 |
| 25 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.03161974 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.98924479 |
| 27 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.98304404 |
| 28 | * MYB_26560356_Chip-Seq_TH1_Human | 1.97777754 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96146507 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.95005599 |
| 31 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.94874407 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.93435882 |
| 33 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.92733951 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.92702878 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.91146813 |
| 36 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.85714284 |
| 37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.84869529 |
| 38 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.83945383 |
| 39 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.83723880 |
| 40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.82301996 |
| 41 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.80572696 |
| 42 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.77435199 |
| 43 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.76651054 |
| 44 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.74526805 |
| 45 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.67264560 |
| 46 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.65824157 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.64607171 |
| 48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.63056749 |
| 49 | * MAF_26560356_Chip-Seq_TH2_Human | 1.60268882 |
| 50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.57910805 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52839574 |
| 52 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48562116 |
| 53 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45662740 |
| 54 | GATA3_26560356_Chip-Seq_TH2_Human | 1.44399549 |
| 55 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.38682189 |
| 56 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36819304 |
| 57 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.36687127 |
| 58 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34966707 |
| 59 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33917620 |
| 60 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28915813 |
| 61 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28914115 |
| 62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26715997 |
| 63 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.22474716 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21818340 |
| 65 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20094403 |
| 66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19244664 |
| 67 | GATA1_19941826_ChIP-Seq_K562_Human | 1.18765702 |
| 68 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18267541 |
| 69 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.16978191 |
| 70 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.16332013 |
| 71 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15095032 |
| 72 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14407058 |
| 73 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.13289590 |
| 74 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.12801938 |
| 75 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11104026 |
| 76 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10771873 |
| 77 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.10545076 |
| 78 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07773918 |
| 79 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06706586 |
| 80 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06117111 |
| 81 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.06080907 |
| 82 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.06076909 |
| 83 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04835895 |
| 84 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04398458 |
| 85 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04266315 |
| 86 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04220666 |
| 87 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.04024790 |
| 88 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.03242986 |
| 89 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.02930001 |
| 90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02401993 |
| 91 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.00584508 |
| 92 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.98018488 |
| 93 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97735309 |
| 94 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96442996 |
| 95 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.95884720 |
| 96 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.95679608 |
| 97 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95017263 |
| 98 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.94619565 |
| 99 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.94106126 |
| 100 | ATF3_27146783_Chip-Seq_COLON_Human | 0.94095868 |
| 101 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.93624240 |
| 102 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93291467 |
| 103 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91901915 |
| 104 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91746176 |
| 105 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.90806083 |
| 106 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90607188 |
| 107 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.90500334 |
| 108 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.89759623 |
| 109 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89669296 |
| 110 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.89611466 |
| 111 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87851684 |
| 112 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.86587933 |
| 113 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.86360728 |
| 114 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.85411653 |
| 115 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85220308 |
| 116 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85083400 |
| 117 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.84606537 |
| 118 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.84603798 |
| 119 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.84233816 |
| 120 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83441060 |
| 121 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.82995902 |
| 122 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.82626938 |
| 123 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.82299059 |
| 124 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.80678178 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.27133149 |
| 2 | MP0000685_abnormal_immune_system | 3.21536551 |
| 3 | MP0003763_abnormal_thymus_physiology | 2.85935234 |
| 4 | MP0003436_decreased_susceptibility_to | 2.83465041 |
| 5 | MP0003303_peritoneal_inflammation | 2.81776463 |
| 6 | MP0005671_abnormal_response_to | 2.63064837 |
| 7 | MP0005387_immune_system_phenotype | 2.62191517 |
| 8 | MP0001790_abnormal_immune_system | 2.62191517 |
| 9 | MP0001800_abnormal_humoral_immune | 2.57377537 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.54554373 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.45484216 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.38413741 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.33383785 |
| 14 | MP0001819_abnormal_immune_cell | 2.31508721 |
| 15 | MP0009785_altered_susceptibility_to | 2.30076378 |
| 16 | MP0005025_abnormal_response_to | 2.24906625 |
| 17 | MP0002723_abnormal_immune_serum | 2.23392215 |
| 18 | MP0002398_abnormal_bone_marrow | 2.14366191 |
| 19 | MP0009333_abnormal_splenocyte_physiolog | 2.11027981 |
| 20 | MP0002419_abnormal_innate_immunity | 2.10374256 |
| 21 | MP0002405_respiratory_system_inflammati | 2.10083142 |
| 22 | MP0002166_altered_tumor_susceptibility | 2.04967835 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.02624016 |
| 24 | MP0004947_skin_inflammation | 1.99874818 |
| 25 | MP0010352_gastrointestinal_tract_polyps | 1.96221424 |
| 26 | MP0009278_abnormal_bone_marrow | 1.94130794 |
| 27 | MP0000716_abnormal_immune_system | 1.91742603 |
| 28 | MP0002396_abnormal_hematopoietic_system | 1.90635060 |
| 29 | MP0001873_stomach_inflammation | 1.90426377 |
| 30 | MP0004381_abnormal_hair_follicle | 1.90343931 |
| 31 | MP0006082_CNS_inflammation | 1.88619432 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.87715465 |
| 33 | MP0002722_abnormal_immune_system | 1.75628272 |
| 34 | MP0008260_abnormal_autophagy | 1.74050928 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.73842412 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.72339424 |
| 37 | MP0003566_abnormal_cell_adhesion | 1.69838773 |
| 38 | MP0000858_altered_metastatic_potential | 1.66820278 |
| 39 | MP0002429_abnormal_blood_cell | 1.65678846 |
| 40 | MP0002006_tumorigenesis | 1.65049190 |
| 41 | MP0010234_abnormal_vibrissa_follicle | 1.62783655 |
| 42 | MP0005397_hematopoietic_system_phenotyp | 1.60582946 |
| 43 | MP0001545_abnormal_hematopoietic_system | 1.60582946 |
| 44 | MP0000703_abnormal_thymus_morphology | 1.60196789 |
| 45 | MP0005076_abnormal_cell_differentiation | 1.59161152 |
| 46 | MP0004808_abnormal_hematopoietic_stem | 1.57414730 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.56078499 |
| 48 | MP0002933_joint_inflammation | 1.52869997 |
| 49 | MP0003448_altered_tumor_morphology | 1.51111379 |
| 50 | MP0005058_abnormal_lysosome_morphology | 1.49940328 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.48617792 |
| 52 | MP0001853_heart_inflammation | 1.47462209 |
| 53 | MP0006054_spinal_hemorrhage | 1.46113949 |
| 54 | MP0005451_abnormal_body_composition | 1.45154586 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.44773637 |
| 56 | MP0003724_increased_susceptibility_to | 1.43472894 |
| 57 | MP0003866_abnormal_defecation | 1.42795654 |
| 58 | MP0000490_abnormal_crypts_of | 1.35468158 |
| 59 | MP0004510_myositis | 1.34240067 |
| 60 | MP0009764_decreased_sensitivity_to | 1.32399495 |
| 61 | MP0005310_abnormal_salivary_gland | 1.31862447 |
| 62 | MP0004883_abnormal_blood_vessel | 1.31098827 |
| 63 | MP0005023_abnormal_wound_healing | 1.30254265 |
| 64 | MP0003453_abnormal_keratinocyte_physiol | 1.29017971 |
| 65 | MP0002277_abnormal_respiratory_mucosa | 1.26576189 |
| 66 | MP0003705_abnormal_hypodermis_morpholog | 1.26359986 |
| 67 | MP0001958_emphysema | 1.17168609 |
| 68 | MP0001851_eye_inflammation | 1.12400280 |
| 69 | MP0005075_abnormal_melanosome_morpholog | 1.11076791 |
| 70 | MP0000343_altered_response_to | 1.10008716 |
| 71 | MP0003091_abnormal_cell_migration | 1.04424444 |
| 72 | MP0003045_fibrosis | 1.02980809 |
| 73 | MP0002019_abnormal_tumor_incidence | 1.02524160 |
| 74 | MP0008469_abnormal_protein_level | 1.01498041 |
| 75 | MP0010307_abnormal_tumor_latency | 0.98797644 |
| 76 | MP0002009_preneoplasia | 0.98638755 |
| 77 | MP0003172_abnormal_lysosome_physiology | 0.97820476 |
| 78 | MP0002138_abnormal_hepatobiliary_system | 0.95892634 |
| 79 | MP0004185_abnormal_adipocyte_glucose | 0.95627378 |
| 80 | MP0005164_abnormal_response_to | 0.94701692 |
| 81 | MP0003690_abnormal_glial_cell | 0.89292843 |
| 82 | MP0003191_abnormal_cellular_cholesterol | 0.89020742 |
| 83 | MP0002998_abnormal_bone_remodeling | 0.88411720 |
| 84 | MP0003075_altered_response_to | 0.87402463 |
| 85 | MP0005166_decreased_susceptibility_to | 0.87107667 |
| 86 | MP0001216_abnormal_epidermal_layer | 0.84426721 |
| 87 | MP0001348_abnormal_lacrimal_gland | 0.82106700 |
| 88 | MP0009763_increased_sensitivity_to | 0.81955033 |
| 89 | MP0003279_aneurysm | 0.81771363 |
| 90 | MP0002877_abnormal_melanocyte_morpholog | 0.80730086 |
| 91 | MP0004130_abnormal_muscle_cell | 0.80693287 |
| 92 | MP0002254_reproductive_system_inflammat | 0.78776509 |
| 93 | MP0002136_abnormal_kidney_physiology | 0.76507589 |
| 94 | MP0004957_abnormal_blastocyst_morpholog | 0.75647922 |
| 95 | MP0003795_abnormal_bone_structure | 0.75136591 |
| 96 | MP0000733_abnormal_muscle_development | 0.74862094 |
| 97 | MP0003077_abnormal_cell_cycle | 0.74729633 |
| 98 | MP0003656_abnormal_erythrocyte_physiolo | 0.74492030 |
| 99 | MP0003693_abnormal_embryo_hatching | 0.71641525 |
| 100 | MP0001915_intracranial_hemorrhage | 0.71611385 |
| 101 | MP0000377_abnormal_hair_follicle | 0.70527949 |
| 102 | MP0005390_skeleton_phenotype | 0.70022285 |
| 103 | MP0000604_amyloidosis | 0.69198816 |
| 104 | MP0000477_abnormal_intestine_morphology | 0.68838893 |
| 105 | MP0009765_abnormal_xenobiotic_induced | 0.68602702 |
| 106 | MP0002796_impaired_skin_barrier | 0.68246534 |
| 107 | MP0002132_abnormal_respiratory_system | 0.66889782 |
| 108 | MP0003183_abnormal_peptide_metabolism | 0.66756666 |
| 109 | MP0000015_abnormal_ear_pigmentation | 0.66569664 |
| 110 | MP0009931_abnormal_skin_appearance | 0.65856892 |
| 111 | MP0008007_abnormal_cellular_replicative | 0.65834271 |
| 112 | MP0005501_abnormal_skin_physiology | 0.64979952 |
| 113 | MP0001663_abnormal_digestive_system | 0.64834481 |
| 114 | MP0008438_abnormal_cutaneous_collagen | 0.64302264 |
| 115 | MP0005174_abnormal_tail_pigmentation | 0.63597297 |
| 116 | MP0008961_abnormal_basal_metabolism | 0.63527331 |
| 117 | MP0003828_pulmonary_edema | 0.62483882 |
| 118 | MP0000249_abnormal_blood_vessel | 0.62401836 |
| 119 | MP0005621_abnormal_cell_physiology | 0.62347663 |
| 120 | MP0001986_abnormal_taste_sensitivity | 0.59867452 |
| 121 | MP0008874_decreased_physiological_sensi | 0.56316246 |
| 122 | MP0008004_abnormal_stomach_pH | 0.55091033 |
| 123 | MP0003221_abnormal_cardiomyocyte_apopto | 0.52770824 |
| 124 | MP0002693_abnormal_pancreas_physiology | 0.52326634 |
| 125 | MP0004264_abnormal_extraembryonic_tissu | 0.50518407 |
| 126 | MP0002133_abnormal_respiratory_system | 0.46208005 |
| 127 | MP0005388_respiratory_system_phenotype | 0.46208005 |
| 128 | MP0002332_abnormal_exercise_endurance | 0.42046952 |
| 129 | MP0004484_altered_response_of | 0.40269518 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.52733876 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.41317745 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.25312897 |
| 4 | Chronic otitis media (HP:0000389) | 4.07387859 |
| 5 | Recurrent fungal infections (HP:0002841) | 3.73500038 |
| 6 | Encephalitis (HP:0002383) | 3.73377873 |
| 7 | Nasal polyposis (HP:0100582) | 3.71130937 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 3.69575653 |
| 9 | Myositis (HP:0100614) | 3.66903351 |
| 10 | Keratoconjunctivitis sicca (HP:0001097) | 3.60125564 |
| 11 | Recurrent bronchitis (HP:0002837) | 3.57605162 |
| 12 | Recurrent viral infections (HP:0004429) | 3.55147421 |
| 13 | Pustule (HP:0200039) | 3.51153889 |
| 14 | Abnormality of the nasal mucosa (HP:0000433) | 3.50471996 |
| 15 | IgM deficiency (HP:0002850) | 3.48995561 |
| 16 | T lymphocytopenia (HP:0005403) | 3.44813420 |
| 17 | Abnormality of T cell number (HP:0011839) | 3.42321688 |
| 18 | Keratoconjunctivitis (HP:0001096) | 3.35145706 |
| 19 | Interstitial pulmonary disease (HP:0006530) | 3.27303035 |
| 20 | Cellulitis (HP:0100658) | 3.18720483 |
| 21 | Abnormality of T cells (HP:0002843) | 3.03423153 |
| 22 | Abnormality of macrophages (HP:0004311) | 2.96978940 |
| 23 | Autoimmune thrombocytopenia (HP:0001973) | 2.94735134 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.87804789 |
| 25 | Gastrointestinal inflammation (HP:0004386) | 2.86833727 |
| 26 | Increased IgE level (HP:0003212) | 2.85830213 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 2.85244404 |
| 28 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.85244404 |
| 29 | Spontaneous hematomas (HP:0007420) | 2.84847352 |
| 30 | Inflammation of the large intestine (HP:0002037) | 2.83555735 |
| 31 | Recurrent skin infections (HP:0001581) | 2.79335322 |
| 32 | Mediastinal lymphadenopathy (HP:0100721) | 2.73546186 |
| 33 | Increased IgM level (HP:0003496) | 2.72718780 |
| 34 | Thrombocytosis (HP:0001894) | 2.69587062 |
| 35 | Colitis (HP:0002583) | 2.64618652 |
| 36 | Hypochromic anemia (HP:0001931) | 2.62366915 |
| 37 | Anorexia (HP:0002039) | 2.61474907 |
| 38 | Gingival bleeding (HP:0000225) | 2.61311460 |
| 39 | Pulmonary embolism (HP:0002204) | 2.59409317 |
| 40 | Panhypogammaglobulinemia (HP:0003139) | 2.57376567 |
| 41 | Hypochromic microcytic anemia (HP:0004840) | 2.57324688 |
| 42 | Verrucae (HP:0200043) | 2.55152188 |
| 43 | Papilloma (HP:0012740) | 2.55152188 |
| 44 | Meningitis (HP:0001287) | 2.55036250 |
| 45 | Agammaglobulinemia (HP:0004432) | 2.54438804 |
| 46 | Epistaxis (HP:0000421) | 2.54268547 |
| 47 | Petechiae (HP:0000967) | 2.53110240 |
| 48 | Abnormality of T cell physiology (HP:0011840) | 2.51135123 |
| 49 | Orchitis (HP:0100796) | 2.50772521 |
| 50 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.49192723 |
| 51 | Hematochezia (HP:0002573) | 2.48584630 |
| 52 | Lymphopenia (HP:0001888) | 2.47241315 |
| 53 | Episodic fever (HP:0001954) | 2.47174075 |
| 54 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.46649507 |
| 55 | Obstructive lung disease (HP:0006536) | 2.46516603 |
| 56 | Chronic obstructive pulmonary disease (HP:0006510) | 2.46516603 |
| 57 | Leukocytosis (HP:0001974) | 2.41455916 |
| 58 | Vasculitis (HP:0002633) | 2.37544139 |
| 59 | Vacuolated lymphocytes (HP:0001922) | 2.37055258 |
| 60 | Cerebral aneurysm (HP:0004944) | 2.33837689 |
| 61 | Slow saccadic eye movements (HP:0000514) | 2.33233681 |
| 62 | Gangrene (HP:0100758) | 2.30441365 |
| 63 | Emphysema (HP:0002097) | 2.26353377 |
| 64 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.25313445 |
| 65 | Abnormality of the pleura (HP:0002103) | 2.24754799 |
| 66 | Skin ulcer (HP:0200042) | 2.23189303 |
| 67 | Osteolytic defects of the hand bones (HP:0009699) | 2.22615560 |
| 68 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.22615560 |
| 69 | Stomatitis (HP:0010280) | 2.20256674 |
| 70 | Combined immunodeficiency (HP:0005387) | 2.20171997 |
| 71 | Increased cerebral lipofuscin (HP:0011813) | 2.20076768 |
| 72 | Eosinophilia (HP:0001880) | 2.19580479 |
| 73 | Fatigue (HP:0012378) | 2.17705489 |
| 74 | Periodontitis (HP:0000704) | 2.17275616 |
| 75 | Gingivitis (HP:0000230) | 2.12932990 |
| 76 | Increased density of long bones (HP:0006392) | 2.11290438 |
| 77 | Hypergammaglobulinemia (HP:0010702) | 2.11072703 |
| 78 | Gastrointestinal stroma tumor (HP:0100723) | 2.10409193 |
| 79 | Dysostosis multiplex (HP:0000943) | 2.08186443 |
| 80 | Microcytic anemia (HP:0001935) | 2.06184912 |
| 81 | Subacute progressive viral hepatitis (HP:0006572) | 2.05909354 |
| 82 | Bronchitis (HP:0012387) | 2.05097273 |
| 83 | Severe combined immunodeficiency (HP:0004430) | 2.04584467 |
| 84 | Chest pain (HP:0100749) | 2.04545881 |
| 85 | Arterial thrombosis (HP:0004420) | 2.03324954 |
| 86 | Glomerulopathy (HP:0100820) | 2.00952886 |
| 87 | Urticaria (HP:0001025) | 1.98882010 |
| 88 | Granulocytopenia (HP:0001913) | 1.98102324 |
| 89 | Abnormality of the peritoneum (HP:0002585) | 1.97561308 |
| 90 | Aortic aneurysm (HP:0004942) | 1.97492380 |
| 91 | Abnormality of the fingertips (HP:0001211) | 1.97364570 |
| 92 | Abnormality of the endocardium (HP:0004306) | 1.97233997 |
| 93 | Abnormality of eosinophils (HP:0001879) | 1.96990744 |
| 94 | Optic neuritis (HP:0100653) | 1.96832809 |
| 95 | Retrobulbar optic neuritis (HP:0100654) | 1.96832809 |
| 96 | Joint swelling (HP:0001386) | 1.96315859 |
| 97 | IgG deficiency (HP:0004315) | 1.95467414 |
| 98 | Autoimmune hemolytic anemia (HP:0001890) | 1.93912346 |
| 99 | Papilledema (HP:0001085) | 1.93820058 |
| 100 | Chronic diarrhea (HP:0002028) | 1.93653282 |
| 101 | Osteomyelitis (HP:0002754) | 1.92025709 |
| 102 | Keratitis (HP:0000491) | 1.91517389 |
| 103 | Vertigo (HP:0002321) | 1.89779321 |
| 104 | Premature loss of primary teeth (HP:0006323) | 1.89707776 |
| 105 | Acute hepatic failure (HP:0006554) | 1.88699767 |
| 106 | Acne (HP:0001061) | 1.88058746 |
| 107 | Chronic sinusitis (HP:0011109) | 1.87667365 |
| 108 | Hemoptysis (HP:0002105) | 1.87011974 |
| 109 | Amyloidosis (HP:0011034) | 1.86162068 |
| 110 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.85895706 |
| 111 | IgA deficiency (HP:0002720) | 1.85082650 |
| 112 | Persistence of primary teeth (HP:0006335) | 1.84628586 |
| 113 | Loss of speech (HP:0002371) | 1.84021832 |
| 114 | Thyroiditis (HP:0100646) | 1.83900189 |
| 115 | Pulmonary infiltrates (HP:0002113) | 1.82037260 |
| 116 | Abnormality of the pericardium (HP:0001697) | 1.81995990 |
| 117 | Gastrointestinal infarctions (HP:0005244) | 1.81186442 |
| 118 | Prolonged bleeding time (HP:0003010) | 1.79656802 |
| 119 | Peritonitis (HP:0002586) | 1.79280812 |
| 120 | Skin rash (HP:0000988) | 1.77429776 |
| 121 | Viral hepatitis (HP:0006562) | 1.75856287 |
| 122 | Impaired platelet aggregation (HP:0003540) | 1.73383251 |
| 123 | Abnormal platelet function (HP:0011869) | 1.73383251 |
| 124 | Bicuspid aortic valve (HP:0001647) | 1.72625506 |
| 125 | Sepsis (HP:0100806) | 1.72620754 |
| 126 | Thin bony cortex (HP:0002753) | 1.71775117 |
| 127 | Abnormality of B cell number (HP:0010975) | 1.69327170 |
| 128 | B lymphocytopenia (HP:0010976) | 1.69327170 |
| 129 | Abnormal platelet volume (HP:0011876) | 1.67404213 |
| 130 | Restrictive lung disease (HP:0002091) | 1.67251473 |
| 131 | Mucopolysacchariduria (HP:0008155) | 1.66313659 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.16737008 |
| 2 | TRIB3 | 3.24505853 |
| 3 | STK10 | 3.22379298 |
| 4 | PRPF4B | 2.71426275 |
| 5 | TYK2 | 2.43671792 |
| 6 | ERN1 | 2.41269663 |
| 7 | LRRK2 | 2.37848390 |
| 8 | EEF2K | 2.34968784 |
| 9 | BLK | 2.34408572 |
| 10 | ZAP70 | 2.33459105 |
| 11 | MAP3K10 | 2.29249793 |
| 12 | JAK3 | 2.27103522 |
| 13 | PKN2 | 2.08276763 |
| 14 | TBK1 | 1.96359136 |
| 15 | TXK | 1.95292598 |
| 16 | EPHB1 | 1.94006676 |
| 17 | ITK | 1.89393486 |
| 18 | GRK6 | 1.88142820 |
| 19 | TNK2 | 1.87549769 |
| 20 | TESK2 | 1.84434508 |
| 21 | FGFR4 | 1.83012301 |
| 22 | TAOK3 | 1.80695179 |
| 23 | BTK | 1.72654670 |
| 24 | CSK | 1.69988128 |
| 25 | IKBKE | 1.62493766 |
| 26 | SIK3 | 1.56221101 |
| 27 | JAK1 | 1.49262900 |
| 28 | MAP3K14 | 1.48439604 |
| 29 | TGFBR2 | 1.46779557 |
| 30 | IRAK4 | 1.46727207 |
| 31 | MST4 | 1.45172015 |
| 32 | RPS6KA4 | 1.44224044 |
| 33 | KIT | 1.39699501 |
| 34 | PTK6 | 1.39249566 |
| 35 | TESK1 | 1.28518322 |
| 36 | CSF1R | 1.24365537 |
| 37 | RIPK1 | 1.23046356 |
| 38 | NME2 | 1.20923638 |
| 39 | PAK4 | 1.18033105 |
| 40 | HCK | 1.17468511 |
| 41 | LCK | 1.15987222 |
| 42 | FGFR3 | 1.14922371 |
| 43 | MAP3K1 | 1.14380663 |
| 44 | SYK | 1.10941851 |
| 45 | TEC | 1.10775899 |
| 46 | KSR2 | 1.10325961 |
| 47 | MAP3K13 | 1.08281366 |
| 48 | KDR | 1.07899559 |
| 49 | BMPR2 | 1.07395691 |
| 50 | PIM1 | 1.05702890 |
| 51 | FLT3 | 1.05558973 |
| 52 | YES1 | 1.04896365 |
| 53 | IKBKB | 1.04390278 |
| 54 | MAP2K3 | 1.02370329 |
| 55 | MAP3K8 | 1.02273719 |
| 56 | TTN | 1.01235358 |
| 57 | EPHA3 | 1.00767954 |
| 58 | PIM2 | 0.99933343 |
| 59 | CLK1 | 0.97345251 |
| 60 | NLK | 0.95921580 |
| 61 | MARK2 | 0.95281045 |
| 62 | MARK3 | 0.94101257 |
| 63 | IRAK1 | 0.88597438 |
| 64 | PDK1 | 0.84925201 |
| 65 | CHUK | 0.80495063 |
| 66 | SMG1 | 0.80427138 |
| 67 | RPS6KB2 | 0.80119733 |
| 68 | DMPK | 0.77676381 |
| 69 | JAK2 | 0.75106376 |
| 70 | CDK12 | 0.74522489 |
| 71 | CAMKK1 | 0.72188433 |
| 72 | MAP3K2 | 0.71053607 |
| 73 | MAP3K3 | 0.70442597 |
| 74 | SCYL2 | 0.69534367 |
| 75 | CAMKK2 | 0.69460018 |
| 76 | CDC42BPA | 0.69433115 |
| 77 | LYN | 0.69381826 |
| 78 | FES | 0.67783398 |
| 79 | IRAK2 | 0.67445628 |
| 80 | RIPK4 | 0.67413669 |
| 81 | MAP3K7 | 0.67200757 |
| 82 | NEK2 | 0.66721147 |
| 83 | CDK4 | 0.66388103 |
| 84 | MAP3K11 | 0.65595743 |
| 85 | TGFBR1 | 0.64613050 |
| 86 | FYN | 0.64553378 |
| 87 | TAOK1 | 0.64093873 |
| 88 | TAOK2 | 0.64041476 |
| 89 | PDGFRB | 0.63461981 |
| 90 | PDPK1 | 0.62636528 |
| 91 | ILK | 0.62250322 |
| 92 | FGR | 0.62094855 |
| 93 | MAPK12 | 0.62060159 |
| 94 | TYRO3 | 0.61640561 |
| 95 | ALK | 0.60803744 |
| 96 | CDK6 | 0.60130944 |
| 97 | DYRK1B | 0.60018940 |
| 98 | MAPK7 | 0.60007028 |
| 99 | PTK2 | 0.59770105 |
| 100 | MAPKAPK3 | 0.59663442 |
| 101 | STK4 | 0.59377947 |
| 102 | TRPM7 | 0.58687129 |
| 103 | MAP3K6 | 0.57166496 |
| 104 | MATK | 0.56182790 |
| 105 | PIK3CG | 0.55992916 |
| 106 | MAPKAPK2 | 0.55193288 |
| 107 | BMX | 0.54212288 |
| 108 | SGK3 | 0.53225765 |
| 109 | RET | 0.51977910 |
| 110 | GRK7 | 0.51719919 |
| 111 | STK38 | 0.49767734 |
| 112 | PTK2B | 0.49088502 |
| 113 | PRKCQ | 0.48836300 |
| 114 | SIK1 | 0.47750002 |
| 115 | HIPK2 | 0.46304871 |
| 116 | NEK9 | 0.45733383 |
| 117 | MAP2K2 | 0.44650410 |
| 118 | PRKCH | 0.44495520 |
| 119 | RPS6KC1 | 0.42705186 |
| 120 | RPS6KL1 | 0.42705186 |
| 121 | STK11 | 0.41907870 |
| 122 | PDGFRA | 0.41525110 |
| 123 | MAP2K6 | 0.41263777 |
| 124 | MAPK11 | 0.39179329 |
| 125 | RAF1 | 0.37567855 |
| 126 | PASK | 0.36391020 |
| 127 | PRKD2 | 0.35142799 |
| 128 | SGK2 | 0.35075325 |
| 129 | SIK2 | 0.34312068 |
| 130 | EGFR | 0.32952551 |
| 131 | DYRK3 | 0.31542412 |
| 132 | ABL1 | 0.31514249 |
| 133 | STK3 | 0.30011657 |
| 134 | RPS6KA6 | 0.29922878 |
| 135 | IRAK3 | 0.29682387 |
| 136 | LIMK1 | 0.29279868 |
| 137 | STK24 | 0.28912020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.00259823 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.47371077 |
| 3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.28405710 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.19715021 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.05667445 |
| 6 | Measles_Homo sapiens_hsa05162 | 2.05473635 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.03572192 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.98231158 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.95165731 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.94169490 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.85393142 |
| 12 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.84633885 |
| 13 | Shigellosis_Homo sapiens_hsa05131 | 1.82701661 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.80798708 |
| 15 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.80012754 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.79736077 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.72192157 |
| 18 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.70632323 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.67163541 |
| 20 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.54236957 |
| 21 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.53615145 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.53075634 |
| 23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.47870381 |
| 24 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.47722261 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.47027560 |
| 26 | Apoptosis_Homo sapiens_hsa04210 | 1.46919374 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.46651534 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.42665634 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.40838839 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39135969 |
| 31 | Hepatitis B_Homo sapiens_hsa05161 | 1.35140516 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.34806876 |
| 33 | Tuberculosis_Homo sapiens_hsa05152 | 1.34280667 |
| 34 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.33353798 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.31821640 |
| 36 | Pertussis_Homo sapiens_hsa05133 | 1.29626207 |
| 37 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.27828777 |
| 38 | Allograft rejection_Homo sapiens_hsa05330 | 1.24568910 |
| 39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.23942225 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.23774111 |
| 41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.22722193 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.20226322 |
| 43 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.19932913 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 1.17030920 |
| 45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.15421963 |
| 46 | Malaria_Homo sapiens_hsa05144 | 1.14434060 |
| 47 | Other glycan degradation_Homo sapiens_hsa00511 | 1.12149909 |
| 48 | Platelet activation_Homo sapiens_hsa04611 | 1.10488917 |
| 49 | Lysosome_Homo sapiens_hsa04142 | 1.06075397 |
| 50 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.03784806 |
| 51 | Colorectal cancer_Homo sapiens_hsa05210 | 1.02096257 |
| 52 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.01811256 |
| 53 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.01687098 |
| 54 | HTLV-I infection_Homo sapiens_hsa05166 | 1.00684006 |
| 55 | Ribosome_Homo sapiens_hsa03010 | 0.99174792 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.98946214 |
| 57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.98575882 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.97418699 |
| 59 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.97028930 |
| 60 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.96257662 |
| 61 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.95627376 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.95372953 |
| 63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.91919357 |
| 64 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.89368908 |
| 65 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.84495427 |
| 66 | Adherens junction_Homo sapiens_hsa04520 | 0.84244806 |
| 67 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.82515946 |
| 68 | Endocytosis_Homo sapiens_hsa04144 | 0.82330238 |
| 69 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.81716766 |
| 70 | Focal adhesion_Homo sapiens_hsa04510 | 0.80689495 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79921823 |
| 72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.79227062 |
| 73 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.78826407 |
| 74 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.78234819 |
| 75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.76842432 |
| 76 | DNA replication_Homo sapiens_hsa03030 | 0.75344632 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | 0.74449578 |
| 78 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.74373273 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73358325 |
| 80 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72613244 |
| 81 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72113234 |
| 82 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70060910 |
| 83 | Asthma_Homo sapiens_hsa05310 | 0.68112064 |
| 84 | Bladder cancer_Homo sapiens_hsa05219 | 0.66015227 |
| 85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65484209 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64773602 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63997860 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63964204 |
| 89 | Base excision repair_Homo sapiens_hsa03410 | 0.62141084 |
| 90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61827437 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59813851 |
| 92 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59219505 |
| 93 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55661505 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.55637374 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55389262 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55144395 |
| 97 | Pathways in cancer_Homo sapiens_hsa05200 | 0.55130346 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54967565 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54312604 |
| 100 | Spliceosome_Homo sapiens_hsa03040 | 0.54232569 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54094258 |
| 102 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.52928537 |
| 103 | Prostate cancer_Homo sapiens_hsa05215 | 0.52513854 |
| 104 | Cell cycle_Homo sapiens_hsa04110 | 0.51704356 |
| 105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49733957 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47979205 |
| 107 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.47344382 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46956544 |
| 109 | Phagosome_Homo sapiens_hsa04145 | 0.46710524 |
| 110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44330788 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.43962672 |
| 112 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.41775946 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40872906 |
| 114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38967540 |
| 115 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38606219 |
| 116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38241559 |
| 117 | Glioma_Homo sapiens_hsa05214 | 0.38034962 |
| 118 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.37591310 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.37423337 |
| 120 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37090876 |

